Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-31 Sale | 2023-01-31 9:02 pm | Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer | 11,890 | $1.8696 | $22,230 | 19,535 (Direct) | View |
| 2023-01-17 Sale | 2023-01-17 9:17 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 4,440 | $1.858 | $8,250 | 7,264 (Direct) | View |
| 2023-01-17 Sale | 2023-01-17 9:17 pm | Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer | 4,440 | $1.858 | $8,250 | 7,264 (Direct) | View |
| 2023-01-17 Sale | 2023-01-17 9:16 pm | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 2,159 | $1.858 | $4,011 | 3,491 (Direct) | View |
| 2023-01-17 Sale | 2023-01-17 9:15 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 10,057 | $1.858 | $18,686 | 13,351 (Direct) | View |
| 2023-01-11 Sale | 2023-01-12 9:03 pm | Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer | 8,816 | $1.7238 | $15,197 | 8,121 (Direct) | View |
| 2023-01-11 Sale | 2023-01-12 9:02 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 8,816 | $1.7238 | $15,197 | 8,121 (Direct) | View |
| 2023-01-11 Sale | 2023-01-12 9:01 pm | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 11,292 | $1.7199 | $19,421 | 12,191 (Direct) | View |
| 2023-01-11 Sale | 2023-01-12 9:00 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 31,805 | $1.7227 | $54,791 | 24,882 (Direct) | View |
| 2023-01-04 Sale | 2023-01-04 9:02 pm | Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer | 3,584 | $1.694 | $6,071 | 5,781 (Direct) | View |
| 2023-01-04 Sale | 2023-01-04 9:01 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 1,100 | $1.694 | $1,863 | 1,725 (Direct) | View |
| 2023-01-04 Sale | 2023-01-04 9:01 pm | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 876 | $1.694 | $1,484 | 1,361 (Direct) | View |
| 2023-01-04 Sale | 2023-01-04 9:00 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 5,073 | $1.694 | $8,594 | 6,631 (Direct) | View |
| 2022-09-01 Sale | 2022-09-01 9:00 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 2,536 | $1.9689 | $4,993 | 3,316 (Direct) | View |
| 2022-08-01 Sale | 2022-08-01 9:01 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 2,983 | $1.7735 | $5,290 | 4,829 (Direct) | View |
| 2022-08-01 Sale | 2022-08-01 9:00 pm | Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer | 21,040 | $1.7735 | $37,314 | 34,824 (Direct) | View |
| 2022-07-05 Sale | 2022-07-05 9:00 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 1,973 | $1.6781 | $3,311 | 3,104 (Direct) | View |
| 2022-06-27 Sale | 2022-06-27 9:01 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 2,562 | $1.63 | $4,176 | 3,290 (Direct) | View |
| 2022-05-20 Purchase | 2022-05-23 9:00 pm | Adaptimmune Therapeutics PLC | ADAP | Wood Gavin Chief Financial Officer | 39,000 | $0.2904 | $11,326 | 96,000 (Direct) | View |
| 2022-01-18 Sale | 2022-01-18 9:04 pm | Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer | 4,368 | $3.1918 | $13,942 | 7,336 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-01-17 Option Award | 2023-01-17 9:07 pm | N/A 2033-01-17 | Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer | 1,924,128 | $0 | 1,924,128 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-17 9:06 pm | N/A 2033-01-17 | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 1,912,248 | $0 | 1,912,248 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-17 9:05 pm | N/A 2033-01-17 | Adaptimmune Therapeutics PLC | ADAP | Brewer Joanna Elizabeth Chief Scientific Officer | 1,856,808 | $0 | 1,856,808 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-17 9:04 pm | N/A 2033-01-17 | Adaptimmune Therapeutics PLC | ADAP | TAYTON-MARTIN HELEN KATRINA Chief Business & Strgy Officer | 1,918,392 | $0 | 1,918,392 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-17 9:04 pm | N/A 2033-01-17 | Adaptimmune Therapeutics PLC | ADAP | Wood Gavin Chief Financial Officer | 1,915,056 | $0 | 1,915,056 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-17 9:03 pm | N/A 2033-01-17 | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 1,914,672 | $0 | 1,914,672 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-17 9:02 pm | N/A 2033-01-17 | Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer | 1,902,888 | $0 | 1,902,888 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-17 9:01 pm | N/A 2033-01-17 | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 6,488,496 | $0 | 6,488,496 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-01 5:18 pm | 2023-07-01 2032-07-01 | Adaptimmune Therapeutics PLC | ADAP | Behbahani Ali Director | 737,050 | $0 | 737,050 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-01 5:03 pm | 2023-07-01 2032-07-01 | Adaptimmune Therapeutics PLC | ADAP | Zaks Tal Zvi Director | 500,000 | $0 | 500,000 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-01 5:03 pm | 2023-07-01 2032-07-01 | Adaptimmune Therapeutics PLC | ADAP | Alleva Lawrence M Director | 816,067 | $0 | 816,067 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-01 5:02 pm | 2023-07-01 2032-07-01 | Adaptimmune Therapeutics PLC | ADAP | Furey John Director | 500,000 | $0 | 500,000 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-01 5:02 pm | 2023-07-01 2032-07-01 | Adaptimmune Therapeutics PLC | ADAP | Noble James Director | 710,711 | $0 | 710,711 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-01 5:01 pm | 2023-07-01 2032-07-02 | Adaptimmune Therapeutics PLC | ADAP | Sigal Charles Elliott Director | 737,050 | $0 | 737,050 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-01 5:01 pm | 2023-07-01 2032-07-01 | Adaptimmune Therapeutics PLC | ADAP | Duncan Barbara Gayle Director | 500,000 | $0 | 500,000 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-01 5:00 pm | 2023-07-01 2032-07-01 | Adaptimmune Therapeutics PLC | ADAP | MOTT DAVID M Director | 1,000,439 | $0 | 1,000,439 (Direct) | View |
| 2022-05-04 Option Award | 2022-05-04 9:03 pm | N/A 2032-05-04 | Adaptimmune Therapeutics PLC | ADAP | Brewer Joanna Elizabeth Chief Scientific Officer | 557,304 | $0 | 557,304 (Direct) | View |
| 2022-01-31 Option Award | 2022-01-31 9:05 pm | N/A 2032-01-31 | Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer | 4,466,376 | $0 | 4,466,376 (Direct) | View |